Streetbeat News

Products Services

HPE

Raymond James analyst Simon Leopold has upgraded Hewlett Packard Enterprise (HPE) stock to Strong Buy from Outperform, raising the price target to $29 from $23, citing a boom in AI server demand.

Portfolio Pulse from

November 18, 2024 | 5:00 pm

NIO

NIO, a leading EV company, has seen significant stock price fluctuations since its NYSE debut. Despite recent challenges, including a dip in stock price and reduced investment by the Swiss National Bank, NIO is expanding internationally and innovating with battery swap technology. Analysts predict substantial stock price growth through 2030, driven by increased vehicle deliveries, international expansion, and advancements in technology.

Portfolio Pulse from

November 18, 2024 | 5:00 pm

BNET

Bion Environmental Technologies, Inc. (OTC QB: BNET) has released an update and outlook, highlighting its position as a leader in advanced livestock and organic waste treatment technology.

Portfolio Pulse from

November 18, 2024 | 5:00 pm

KEYS

Keysight Technologies has entered into an agreement to provide its EDA software to six of the eight hubs involved in the U.S. Microelectronics Commons initiative, supporting advancements in microelectronics.

Portfolio Pulse from

November 18, 2024 | 5:00 pm

INBS

Intelligent Bio Solutions (INBS) reported strong initial results from its pharmacokinetic study, crucial for FDA submission of its Intelligent Fingerprinting Drug Screening System. Despite this positive development, INBS stock declined.

Portfolio Pulse from

November 18, 2024 | 5:00 pm

CLOV

Clover Health's stock has dipped 32% after Q3 earnings, presenting a potential buying opportunity. The company is improving its financial performance and has received a 4-star rating upgrade for 2026, which could boost market share and secure more deals.

Portfolio Pulse from

November 18, 2024 | 5:00 pm

NBRI

North Bay Resources Inc. (OTC:NBRI) has achieved a significant milestone by producing its first gold concentrates at the Bishop Gold Mill, with gold recovered from the Fran Gold Project within six weeks of ore delivery.

Portfolio Pulse from

November 18, 2024 | 5:00 pm

CRDL

Cardiol Therapeutics Inc. reported positive Phase II clinical results for its CardiolRx™ treatment in recurrent pericarditis, showing sustained reductions in pain and inflammation over 26 weeks. These results support advancing to further clinical trials.

Portfolio Pulse from

November 18, 2024 | 5:00 pm

BABA

Alibaba is facing stagnation with minimal revenue growth and underperforming platforms. Political risks and lack of growth strategies are concerning, with Alibaba Cloud lagging behind industry leaders.

Portfolio Pulse from

November 18, 2024 | 5:00 pm

BJ

BJ's Wholesale is expected to report positive Q3 earnings, driven by better pricing, private-label offerings, merchandise initiatives, and digital solutions.

Portfolio Pulse from

November 18, 2024 | 4:45 pm